Aimovig 140 (Erenumab PFS) 140mg/ml x1ml

Aimovig 140 is a prescription injection for migraine prevention. It contains erenumab, a CGRP receptor antagonist, designed to reduce migraine frequency. This single-dose prefilled syringe provides 140mg per ml. Store between 2-8°C to maintain potency.

Strength

140mg/ml x1ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Novartis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aimovig 140 is used to prevent migraines in adults. It belongs to a class of medications that block calcitonin gene-related peptide (CGRP) receptors, which play a role in migraine attacks. People often ask, 'what is Aimovig 140 used for' when seeking alternatives for migraine management. It is not intended for acute migraine treatment.

Side Effects

Aimovig 140 helps reduce the number of migraine days per month for many users. Some patients report fewer severe headaches and improved daily functioning. Individual responses vary, and consistent use over time may be required to assess full benefits. Side effects are typically mild and may include injection site reactions.

Precautions & Warnings

Keep Aimovig 140 refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Before use, allow the prefilled syringe to reach room temperature for about 30 minutes. Discard any unused portion after one use. Consult a healthcare provider if you have latex sensitivity, as the needle cap contains dry natural rubber.

Avoid Interactions

Aimovig 140 has a low potential for drug interactions due to its targeted mechanism. No significant interactions with common medications like pain relievers or triptans have been reported. However, always inform your healthcare provider about all medications and supplements you are taking. Live vaccines should be administered before starting Aimovig if possible.

Frequently Asked Questions

Aimovig 140 is given as a subcutaneous injection once monthly. The prefilled syringe is designed for self-injection after proper training.

Common side effects may include injection site reactions, constipation, or muscle spasms. Severe allergic reactions are rare but require immediate medical attention.

Aimovig 140 is available by prescription only. Some pharmacies offer online ordering with home delivery, subject to local regulations.

Individual responses vary. Some patients may notice reduced migraine frequency within the first month, while others may require longer.

The safety of Aimovig 140 during pregnancy has not been established. Consult a healthcare provider to discuss risks and benefits before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.